EMA committee issues positive opinion to support the approval of GSK’s recombinant zoster vaccine, Shingrix in a prefilled syringe: London, UK Wednesday, October 22, 2025, 16:00 ...

"This is an exhilarating moment for Kraig Labs," said Kim Thompson, Founder and CEO of Kraig Labs. "BAM-1 Alpha represents the next step in the evolution of our spider silk technology. It's the result ...

The latest announcement is out from Novavax ( (NVAX) ).

CPV-104 is the only recombinant Factor H in clinical development and has received EU Orphan Drug Designation for C3GEleva successfully completed ...

As research becomes ever more sophisticated and regulatory requirements tighten, ProPure ™ is a game-changer for life science ...

Oral and inhaled biologics are gaining R&D investment due to patient acceptance and potential for home administration, with ...

Normally, Tau proteins stabilize microtubules and support neuronal function, but in neurodegenerative diseases such as ...

Vaxart, Inc. (OTCQX: VXRT) (“Vaxart”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced that it ...

The global epigenetic antibodies market size is calculated at USD 2.70 billion in 2025 and is expected to reach around USD 12.01 billion by 2034, growing at a CAGR of 18.04% for the forecasted period.

On October 20, 2025, CollPlant Biotechnologies announced positive results from a study conducted by the Technion – Israel Institute of Technology, which demonstrated that its rhCollagen-based bioink, ...

Cha Vaccine Research Institute, an affiliate of Cha Biotech, has unveiled its mid- to long-term growth strategy, focusing on ...

CSL Seqirus real-world study finds cell-based flu vaccines offer stronger protection than egg-based options in 2023/24 season.